List of Biotech, Pharmaceutical & Life Sciences companies in Colorado - 101

ADInstruments is committed to providing innovative tools for research and education. Our company helps scientists and educators achieve their goals with our industry leading PowerLab and LabChart data acquisition systems. Since 1988, life science research has been and continues to be a key driver for innovation in our research product line. Today there are 40,000 ADInstruments data acquisition systems used worldwide in research, and in teaching. Our newest and most innovative product, Lt, takes education a step further with its cloud-based learning platform and 900+ pre-configured physiology, biology, chemistry, medicine, and nursing courses. ADInstruments is a brand synonymous with elegant research and education solutions tailored to suit, and our commitment to our customers is unmatched in our industry. #MakingScienceEasier

Ajna BioSciences is pioneering the development of FDA-approved botanical pharmaceuticals to revolutionize the world of medicine. Our strategy encompasses a focus on select plant and fungi species with a well- established history of therapeutic use, which streamlines the drug discovery process, mitigates late-stage clinical trial risk, and propels us towards unprecedented medicinal breakthroughs. With a specialized infrastructure and industry expertise, we're strategically poised to lead and create significant value in this exciting, nascent category of pharmaceuticals. Join us as we tap into the transformative potential of nature, shaping the future of health and medicine.

Alder Renewables harnesses the power of abundant and sustainable biomass to create a low-carbon to carbon-negative renewable platform.

Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.

Allander biotechnologies is a biotech company at the R&D stage focusing on drug development for unmet medical needs in tissue regeneration.

Founded in 1994, AlloSource is a nonprofit leader in providing allografts that maximize tissue donation to help surgeons heal their patients. The company has grown into one of the largest tissue networks in the country creating more than 200 types of precise bone, skin and soft-tissue allografts for use in an array of life-saving and life-enhancing medical procedures. As a leading manufacturer of cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource’s products bridge the proven science of allografts with the advanced technology of cells. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO.

Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent's individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.

Alpine Research is a Clinical Research Center that conducts clinical trials for major pharmaceutical companies.

Ambrosia Biosciences Inc. is a privately held drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.

Generate a Rapid DNA identification profile, anywhere, in less than 2 hours. FBI NDIS approved. Used around the world in public safety, investigations, disaster victim identification, sexual assault, booking, anti human trafficking, border control, counterterrorism, and environmental protection. The ANDE system is revolutionary with respect to its time to actionable result, ruggedization, complete end-to-end functionality, cost-effectiveness, and ease of use (so easy that a technical operator is not required).

AOA Dx is developing the next frontier in early-stage cancer detection for women through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker ganglioside platform, GlycoLocate™, is paving the way for life-saving early cancer detection. In a first of its kind, AOA Dx is developing AKRIVIS GD™, an early-stage liquid biopsy test for ovarian cancer, that has proven excellent sensitivity and specificity in a recent study. We foresee novel tumor biomarker gangliosides as the future for diagnosis, prognosis, monitoring, and eventually targeted therapies across multiple cancers. AOA Dx was co-founded by three experts and passionate advocates of women's health, who have worked together at two previous diagnostic startups, that both resulted in successful exits upon commercialization. AOA Dx, a Y combinator and VC backed company, raised an oversubscribed Seed Round to accelerate development and clinical studies. Awards & Accelerators: 1. Y Combinator 2. MassChallenge 3. Springboard Enterprises 4. MassMedic Ignite 5. Inc Magazine Top 100 Female Founders 6. Women's Health Innovation Summit Award 7. Massachusetts Life Sciences Center MassNextGen Award 8. The Wave Summit's Emerging Women Founder in Bio Award 9. The Eddies Award 10. Bloomberg New Economy Catalyst www.aoadx.com

ArcherDX is developing and seeking regulatory clearances for next-generation sequencing (NGS) diagnostics to help solve for the underutilization of targeted cancer therapies.

Our mission is to decrease the quantity and severity of infections that cause human suffering through the creation and development of novel, targeted, antimicrobial therapies. Our lead technology, Veriox®, is a first-of-it's-kind, proprietary peracid/hydrogen peroxide based non-systemic antimicrobial agent. Our vision is to improve societal health by protecting humans, animals and the environment from harmful viruses and chemical agents. ArmiClenz™ (EPA registered disinfectant spray, cleaner/odor control) and ArmiVet™ (Topical wound, rash and hot spot care for animals) are two exciting new consumer brands that support our vision.

Arthroventions™ is improving the quality of life for patients with joint disease by developing technologies that enable more effective joint care. Over 70 million Americans (1 in 5) have a form of joint disease. It impacts more people than cancer, there is no cure, and the longer and more active a lifestyle, we live the more likely we will experience it. At Arthroventions, we believe the synovial fluid is the key to diagnosing and treating the different types of joint disease, including Osteoarthritis and Rheumatoid Arthritis. Unlike other chronic diseases, such as cancer, there are no diagnostics assays that can differentiate between disease phenotypes or to predict drug responsiveness. This results in patients receiving ineffective treatments based on physician and payer preference. Our first product line is a Class I medical device that facilitates the aspiration/removal of synovial fluid from and the injection of therapeutics into the joint space, which it is estimated that 30% of these procedures miss the joint space. Our new approach reduces patient pain and decreases the probability of missing the joint space, thereby improving the delivery of therapeutics and patient comfort. Using our devices, physicians and providers can realize additional revenue with improved quality of care. Our products support all types of intra-articular injections, including corticosteroids, viscosupplementation, and new regenerative therapy products such as Platelet Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC), and Adipose derived cells. Join us and take the first step towards more effective joint care.

Aspire Biotech is a biomaterials Research and Development company focused on improving medical devices through the development of superior biomaterials.

Aytu BioPharma (NASDAQ: AYTU) is a dynamic specialty pharmaceutical company with a growing commercial portfolio of prescription medicines addressing complex conditions, with a focus on ADHD and other common conditions. Our evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As we continue on this trajectory, we continue to evaluate novel therapeutics to in-license or acquire.

Our technology was developed by professors at a major University in the US. The formula uses an ingredient that is 100% natural and edible. In fact, the ingredient is already used in many food and beverage products for human consumption. The technology has been field tested by the USDA and has been proven to effectively kill the spotted wing drosophila, an invasive species that is currently decimating fruit crops across North America – costing the US fruit industry over $700 million annually. Key Technology Benefits: Fully field tested by USDA on spotted wing drosophila – 75% reduction in larvae First insecticide that uses an FDA approved GRAS ingredient that is edible by humans and pets Key ingredient both attracts and kills insects Slow acting which allows the insects to carry the insecticide back to the nest for complete extermination Could potentially eliminate the need for health warning labels on product packaging Could save up to $10 Billion in annual insect damage in the US Key ingredient is readily available and cost effective

BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create ADCs with improved internalization and trafficking. Our proprietary tech combines single-cell bioassay engineering, robotics, and ML.

We provide services in genomics, statistics, and information technology. Our services include Bayesian analysis, bioinformatics, biomarker development, biostatistics, data management, data pipelines, data science, epigenomics, genetics, genome-wide association, imputation, microarray analysis, multiomics, next-generation sequencing analysis, pharmacogenomics, polygenic risk scores, predictive modeling, project management, proteomics, reproducibility, software development, statistical computing, statistical genetics, and statistical programming. We also developed the Smokescreen® Genotyping Array, advancing research into addiction and treatment approaches. Our highly-skilled transdisciplinary team of experts, carefully assembled from leading research universities and industry, has been solving our clients' research challenges for almost two decades. Extensive experience with a wide range of cutting-edge methods and technologies means we can help ensure your project's success, and provide high-quality deliverables on time and within budget. Whether you have a critical issue, need help with every aspect of a new project—including coordinating complex projects—or only one part of an ongoing project, we can work with you to develop the optimal solution to meet your goals and objectives. Our team can be an integral part of the collaboration, and provide full-service support for all the stages of your research journey. We follow all U.S. Department of Health & Human Services standards for the security of electronic protected health information (HIPAA-compliant). We believe in reproducible, reusable, transparent, and extensible research, and do everything we can to put those values into practice. We are prepared to use our internal computing environment, cloud-computing environments, or client-provided environments, if preferred.

Bolder BioTechnology has a diversified pipeline of proprietary, long-acting human protein pharmaceuticals that include potential treatments for hematological and endocrine disorders, cancer supportive care, and orphan genetic diseases.

Bond Pet Foods is using fermentation technology to produce ingredients formeat proteins like chicken, turkey, beef, pork and fish for use in pet food.

Cascade Biocatalysts is creates more productive enzymes for economical biomanufacturing of sustainable chemicals. Cascade addresses the growing need for stable, long-lasting biocatalysts using their patent-pending enzyme immobilization platform.

Cerapedics is a global, commercial-stage orthopedics company that aspires to redefine the standard of care for bone repair by healing bones faster and at higher rates, without compromising safety, so that patients can live their healthiest lives. Bone grafts, including Cerapedics’ products, are used in over four million annual spine, orthopedics, trauma and interventional procedures world-wide. Cerapedics’ product, i-FACTOR®, is FDA approved for single-level cervical spinal fusions in the United States. Cerapedics’ next-generation product is currently being evaluated for use in lumbar interbody fusion through ASPIRE, a pivotal IDE study, and has been granted a Breakthrough Device Designation by the FDA. Cerapedics is headquartered in Westminster, CO.

At CereHealth, our mission is to revolutionize healthcare through the power of artificial intelligence. We are committed to improving patient outcomes and enhancing the efficiency of clinical practices by providing cutting-edge AI-driven Clinical Decision Support Solutions (CDSS). Our purpose is to bridge the gap between data and insights, enabling healthcare professionals to make informed and precise decisions at every critical juncture. By harnessing the potential of AI, we aim to empower medical experts with real-time, evidence-based recommendations that promote accurate diagnoses, personalized treatment plans, and optimize patient care. Driven by our dedication to innovation and integrity, we envision a future where healthcare providers can seamlessly integrate AI into their workflows. Through continuous research, collaboration, and advancements in AI technology, we strive to be at the forefront of CDSS, setting new standards for excellence in healthcare decision-making. We are unwavering in our commitment to privacy and security, ensuring that patient data is treated with the utmost confidentiality and adhering to the highest standards of compliance. Our solutions are designed not only to support medical professionals but also to engender trust among patients, knowing that their well-being remains at the heart of every AI-driven recommendation. By working hand in hand with the medical community, we aim to foster a healthcare landscape where AI augments human expertise, leading to faster, more accurate diagnoses, reduced medical errors, and ultimately, improved patient outcomes. At CereHealth, we are dedicated to shaping a healthier tomorrow through the synergy of AI and medical wisdom.

cGMPnow accelerates Gene & Cell Therapy products to patients by providing GMP Manufacturing & QC Laboratory Equipment, Automation & Controls (IT/OT), Commissioning & Qualification, and Procurement services using project-dedicated expert resources.

Cime has harnessed recent advancements in synthetic chemistry to develop a proprietary platform unique to the industry that is faster, more efficient, and more cost effective than current solutions By combining the synthesis and screening stages of drug discovery, we significantly accelerate the Design-Make-Test-Analyze paradigm.

Colorado Serum Company specializesin manufacturingUSDA-licensed large animal biologicals, Colorado Serum Company’s product line includes Serum Antibodies, Bacterins, Toxoids, Bacterin-Toxoids, Antitoxins, Spore, and Modified Live vaccines.

Colorado State University is a Higher Education institution that offers a variety of academic programs and conducts research in various fields.

Compass Biotech offers strategic and technical solutions for pharmaceutical, medical device, diagnostic and biotech industries.

Corgenix is part of the SEBIA Group. Located outside of Denver, Colorado, USA, Corgenix is a CAP/CLIA accredited laboratory specializing in clinical studies, clinical trial management and physician-ordered patient testing. Corgenix is also a experienced in CDMO—Contract Development and Manufacturing Organization. Corgenix is a highly capable strategic partner with history of success; our main client groups are Biotech companies, Pharmaceutical industry, Cancer Centers, and Academic laboratories. Strategic collaborations have covered all aspects of the IVD process –development, quality control, regulatory compliance, manufacturing (We are ISO-13485:2016, an FDA registered facility and GMP compliant), warehousing, distribution, product support, and commercialization. . Whether you need support for research, clinical trial testing or contract clinical testing services, we are here to serve. Above all, we believe in clear communication and transparency. We take a cross-functional team approach to our projects, fully engaging with our clients throughout the project. What do you need? Please contact us to see how we can support your business strategy!

Darwin Biosciences specializes insaliva-based diagnostic tests for infectious disease. We are developing diagnostics that can identify people who are asymptomatic or pre-symptomatic for common infectious diseases, including COVID-19. Some of our products are being designed for clinical use. Others are expected to be hand-held and self-administered, so that people can monitor their own health at home or when reporting for work at venues where vulnerable people (i.e. nursing homes, hospitals) or many people (delivery personnel, airport employees) are being served.

DMC Biotechnologies has developed its Dynamic Metabolic Control technology, a novel, low cost technology for rapid engineering of robust microbial hosts that enables the production of a broad diversity of specialty chemicals, flavors, fragrances, neutracueticals, natural products, pharmaceuticals, and APIs.

Dropworks was formed in 2016 with the idea of transferring high impact serial-flow emulsion microfluidics technologies to high impact areas in healthcare, life sciences, and environmental monitoring.

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.

Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.

enQuire BioReagents is founded to change how scientists are recognized for their contributions to science. If you believe scientists should benefit more from their discoveries, like we do, then shop and learn about enQuire BioReagents at https://enquirebio.com

Exxel Pharma is a pharmaceutical company focused on the development of innovative, small molecule based medicines for management of pain and treatment of neuronal hypersensitivity disorders.

Flagship Biosciences is a leader in spatial biology and biomarker analysis, bringing innovative approaches to clinical research and drug development. The company delivers the most accurate and informative data available in the field of spatial biology and biomarker services.

FluoroFinder is developing innovative cloud-based research tools for the search of fluorescent reagents and the design of medical experiments: accelerating the research initiatives aimed at curing Cancer, HIV, Multiple Sclerosis, in addition to other infectious diseases. Simplifying the complexity of managing the life-cycle of reagent selection, FluoroFinder's technology solutions offers unparalleled support and resources to core facilities and labs. Members receive additional benefits and support to drive efficiencies and resource savings. FluoroFinder's technologies save thousands of days - and millions of dollars - for research institutions every year! Please contact us at info@fluorofinder.com to request a demo.

Foresight Diagnostics is a precision medicine company developing a novel liquid biopsy test for the measurement of minimal residual disease (MRD) for aid in patient management that is funded by leading diagnostics VC firms in Silicon Valley. Foresight’s cell-free DNA testing platform was developed in the labs of two prominent professors at Stanford University and is backed by several major peer-reviewed publications. The company has garnered significant partnering interest from multiple pharmaceutical companies in oncology and is poised for rapid growth. Foresight Diagnostics is headquartered in Aurora, Colorado.

We are a Colorado-based biomaterials company intentionally designing new materials to improve wound healing. Our materials are anti-inflammatory, prevent bacterial adhesion, and are capable of controlled drug delivery.

GenoFAB partners with biotechnology companies and life scientists who need gene delivery solutions. Our clients develop breakthrough genetic medicines targeting challenging diseases that have defeated traditional drug development strategies, including gene therapies, cancer therapies, vaccines, regenerative medicines, and basic research. GenoFAB, through its innovative biofoundry services, engineers unique gene delivery solutions that are tailored to the specific needs of each client's project, setting us apart from standard solutions. Unlike standard gene delivery solutions, GenoFAB's iVectors accelerate product development, streamline the transition to the clinic, and maximize shareholder value by securing defendable intellectual property (IP) positions. GenoFAB, Inc. is a spin-off of Colorado State University (CSU) that has licensed patented technologies developed with funding from the National Institutes of Health, the National Science Foundation, and other federal agencies. Through a contract with CSU, GenoFAB also has access to the services of the Colorado Biofoundry to subcontract part of its clients projects to a high-throughput facility that complements their internal laboratory resources. At GenoFAB, our 'data first' philosophy is more than a belief. It's a strategic approach that underlines the importance of data as a foundational element in the decision-making, development, and operations of R&D projects. This core principle is designed to maximize shareholder value by supporting strong patent claims while ensuring freedom to operate. The GenoFAB patent-pending Biofoundry Operating System is not just a tool. It's a powerful platform that provides unprecedented flexibility, empowering you to manage complex R&D projects. It allows you to define and manage complex workflows that combine experimental steps, computational operations, and supply chain transactions, putting you firmly in control of your projects.

Gevo, Inc. (NASDAQ: GEVO) has a mission to transform renewable energy into low carbon transportation fuels. This next generation of renewable premium gasoline, jet fuel and diesel fuel with the potential to achieve zero carbon emissions, addressing the market need of reducing greenhouse gas emissions with sustainable alternatives. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their lifecycle). Gevo's products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. In addition to addressing the problems of fuels, Gevo's technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo's ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions. Gevo believes that its proven, patented, technology enabling the use of a variety of low-carbon sustainable feedstocks to produce price-competitive low carbon products such as gasoline components, jet fuel, and diesel fuel yields the potential to generate project and corporate returns that justify the build-out of a multi-billion-dollar business.

GID Group’s SVF-2 device and therapy, pending FDA approval, gives providers and patients a major development in cellular medicine to help treat osteoarthritis pain and to delay or provide an alternative to total knee replacement surgery. GID’s technology harvests, isolate and reimplants the right type and combination of one’s own healing cells. Our first FDA-approved pivotal clinical study, a closely watched rigorous trial, had no serious adverse events and showed significant improvements in pain and function. The FDA has granted conditional approval for a second final pivotal clinical trial. Cellular therapy addresses an unmet need in 14 million people living with osteoarthritis of the knee, offering a less time consuming, painful and costly treatment for everyone that requires no joint surgery and no drugs for osteoarthritis pain. Help relieve the $200 billion burden of osteoarthritis management on our healthcare system. Heal intelligently.

GoodBelly is the pioneer of gut health dedicated to improving people's lives with intestinal balance, digestive wellbeing and immunity support when consumed daily through everyday efficacious foods, beverages and supplements. Founded in 2006 with a vision to bring probiotics to the mainstream with functional solutions reliant on the well-studied probiotic strains Lactobacillus Plantarum 299v (LP299V®), GoodBelly is headquartered in Boulder, CO and available at 20,000 stores nationwide in natural, specialty, conventional, mass and convenience retailers.

Green Sun Medical LLC. is a Colorado company dedicated to developing transformative bracing technology to prevent spinal deformity surgery. We have assembled a world class surgeon advisory board of scoliosis thought leaders and veteran industry executives. Our tech enabled dynamic brace will provide precise corrective pressure to patients. For the first time ever, physicians will be able to monitor the performance of a brace in real-time.

Greffex™ is a privately held, multi-national company, headquartered in Aurora, Colorado. Established in 1999, Greffex has developed a novel genetic platform for the development and production of vaccines. Our proprietary GREVAX™ Universal Platform delivers vaccines in a faster, more affordable and more efficient manner. Once a pathogen has been identified, Greffex's team designs and produces a GREVAX™ vaccine in as little as 4 weeks. The state-of-the-art flexibility of the GREVAX™ Universal Platform makes it the ideal delivery vehicle for vaccines against a wide variety of infectious disease, including but not limited to Pandemic Influenza strains, Anthrax and Dengue Fever, as well as Malaria, Hepatitis C, Respiratory Syncytial Virus (RSV), Ebola, HPV, Plague, Tuberculosis and a host of other vaccine candidates.

GT Molecular develops ultrasensitive Molecular Assays, Digital PCR and qPCR Tests End-to-End solutions for cancer detection and waterborne pathogens including SARS-CoV-2. Detect as little as 1-3 molecules of target DNA

HemoGenix® is a contract research service laboratory that specializes in in vitro toxicity testing that even large CROs cannot provide. HemoGenix® has developed many proprietary in vitro testing platforms that have been used by small, medium and half of the top 50 biopharmaceutical companies. Known for attention to detail, high quality service and one-on-one personal and reliable consultation, HemoGenix® provides the expertise to help in predicting toxicity, risk and safety of a drug or other agent. Our portfolio of contract research services is expanding and includes in vitro testing of cells and tissues from GLP or non-GLP pre-clinical animal studies. All of our services are also available through Science Exchange. We look forward to working with you. For assay kits, cell expansion reagents and cell culture media, please visit www.preferred-cell-systems.com, or call (719) 264-6251.

Heska is now an Antech company. Through innovation, invention, and strategic partnerships with worldwide leaders in diagnostics and treatments, Heska provides the benefits of latest generation technologies to veterinary professionals. Heska's range of in-house lab diagnostic solutions include Chemistry, Hematology, Blood Gas & Electrolytes, Immunodiagnostics, Artificial Intelligence-guided Urine & Fecal, Digital Cytology, Heartworm testing, and more. Utilize the highest sensitivity allergy testing available with Heska's immunotherapy solutions. Heska's digital imaging lineup boasts the latest High-Definition Digital Radiography and Digital Ultrasound technologies, paired with Cloud Based data archival, management, and sharing services. Discover all the ways Heska can help provide a voice for your patients.

Impello® Biosciences was founded on a simple premise: biostimulants make horticulture better for everyone. Our integrated solutions, ranging from microorganisms to other bioactive compounds, help farmers everywhere increase the quality and yield of every harvest. Impello addresses tough agricultural challenges with next-generation biotechnology to support a better, healthier, and more sustainable planet.

Implant Surfaces offers surface solutions for spinal, orthopedic, cardiovascular, and neurovascular device and instrument applications. Our advanced nano-engineered coatings and surface treatments enable a wide range of product enhancements including biocompatibility, optimum tissue integration, biofilm resistance, wear and corrosion resistance, reduced friction, hydrophilicity, hydrophobicity, anti-glare surface, aesthetic and color-coding, and desired electrical properties. Our surface modification capabilities include physical vapor deposition (PVD), Atomic Layer Deposition (ALD), Chemical Vapor Deposition (CVD), as well as our proprietary Atomic Plasma Deposition (APD™), Nano Plasma Deposition (NPD™), and Molecular Plasma Deposition (MPD™) processes.

Inocucor supports the ideals of the next Green Revolution with powerful natural biologicalproducts that reduce the need for chemicalinputs on farms and in greenhouses.

INVI MindHealth was founded at the University of Oxford and leverages learnings from the Health Pillar of The SEAL Future Foundation, a 501(c)3 co-founded by Jonathan. INVI combines the power of biometrics, deep learning analytics, and human networks to provide personalized mental health support.

Kelsie is a biotechnology company that specializes in formulating and delivering sensitive Active Pharmaceutical Ingredients (APIs) using its patented Carbon-Dioxide Assisted Nebulization Bubble Drying (CAN-BD) process.

KromaTiD, Inc. provides products and services for mutation detection and disease diagnosis. KromaTiD’s patented dGH™ chromosome imaging platform enables detection of all types of chromosomal rearrangements including previously undetectable cryptic inversions.

Living Ink is a cutting edge materials science company developing the next-generation of ink and coatings. We transform algae cells into renewable, carbon negative and safe pigments and inks. Inks range from publication, packaging to textile and footwear.

MBC Pharma, Inc. is a pharmaceutical company discovering and developing novel medicines for the treatment of oncology, bone and infectious diseases. MBC Pharma's patented technologies improve upon the benefit of known drugs by adding tissue targeting and increased cancer cell specificity and uptake.

We believe that good food should be good for the planet, too. That's why we founded Meati in 2017, right here in Boulder, Colorado. We're on a mission to bring mycelium, one of the most nutrient-dense superfoods on the planet, to kitchen tables all over the world. Made with minimal ingredients, our cutlets and steaks are 95% mycelium. They're high in protein, fiber, vitamins and minerals, and low in carbohydrates, fats and cholesterol. And, most importantly, they're delicious. They're beloved by meat eaters, vegetarians and vegans alike. Created using a natural fermentation process, you won't find any chemicals or preservatives that you can’t pronounce, and you'll also find no pesticides or antibiotics in our products. They're also free of the top nine allergens. You can find Meati in 7,000 stores nationwide, including the Kroger family of stores, Albertsons and Safeway stores, Super Target, Whole Foods Market, Sprouts Farmers Market, Meijer, Fresh Thyme, Natural Grocers, Wegmans, and many more! It's super, naturally. Visit meati.com to learn more about Meati, to see where you can find it, and to check for career opportunities!

MenoGeniX is a privately-held, clinical stage biopharmaceutical company, dedicated to researching and developing a novel potential treatment for women suffering from hot flashes and related vasomotor symptoms of menopause.

Mesa Labs helps you monitor and maintain higher standards in any environment – from the air we breathe to the critical moments of life-saving care. For the past 36 years, Mesa has helped companies protect vulnerable environments and ensure the safety and efficacy of the products we consume every day.

Metabiomics has developed a new type of microbiome diagnostic test for early detection and monitoring of polymicrobial and immunological diseases such as inflammatory bowel disease, colon cancer, HIV infection, alcoholic liver disease, and others that are non-invasive, lower cost, more sensitive and accurate than currently available diagnostic procedures. For the past 10 years, Metabiomics has been a pioneer in human microbiome research specializing in functional metagenomics and systems biology applied to advances in microbial DNA sequencing methods, clinical research, and in vitro diagnostics. Our on-going clinical research is unraveling some of the secret relationships between human microbial communities, immunology, and health. Our research collaborations with Diversigen, the Harvard Chan School of Medicine, Penn State University and George Mason University Microbiome Analysis Center and several medical research institutions are focusing on microbial biomarkers and immunological responses in intestinal dysbiosis, colon disease and cancer, liver disease, and other immunological diseases.

Mountain View Clinical Research, Inc. - clinical trial research site with a focus on neurology, psychiatry, multiple sclerosis, internal medicine and psychedelic IP.

Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.

Researchers and Developers of Cannabinoid-Based Pharmaceuticals in Accordance with U.S. Food and Drug Administration (FDA) Pre-Clinical and Clinical Pathways

Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.

We're bringing something new to the table, delivering thoughtfully-constructed, affordable treatment that works. Our 14-week program combines talk therapy with best in class medication management, including ketamine, for difficult to treat depression, anxiety, and PTSD — because no one should have to live with debilitating mental health conditions that are actually treatable.

At OncoVerity, we're not just developing a new treatment—we're doing something truly unique and meaningful. We're establishing a disruptive model using cutting-edge technology to advance cancer therapies. Our mission is to quickly advance therapies that turn hope into reality for patients, their families, and caregivers.   One of the things that sets OncoVerity apart is our approach. We are knocking down traditional barriers between academia and industry by building a team that bridges both worlds. We believe that cutting-edge technology is essential, but it is only one piece of the puzzle.   The true power behind our vision lies in: The brilliance of our people: Your entrepreneurship, ingenuity, drive, and passion are what will fuel our success. The richness of our diversity: A variety of perspectives and backgrounds is essential for groundbreaking solutions. The strength of our collaboration: We are stronger together, and teamwork is at the heart of everything we do.

OnKure Therapeutics is a precision oncology company committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.

Orbit Genomics is transforming complex disease diagnosis, treatment and prevention through early warning genomics. Our patent pending OrbiSeq™ platform analyzes novel genomic markers which uniquely reflect not only inherited predisposition to disease, but also risk acquired from lifestyle and environmental exposures. OrbiSeq can be applied to diagnose, treat and help prevent complex diseases including cancer, heart disease and neurological diseases. Our first product is an aid to diagnosis for lung cancer, the world’s deadliest cancer and the only major one without a routine screening test. Diagnosis often requires an expensive and invasive biopsy. Our simple blood test will eliminate unnecessary biopsies.

Origin Endoscopy was formed through a collaboration of inventors from Johns Hopkins Medicine and the University of Maryland, and commercial experts in the interventional endoscopy space. Their primary technology is designed to control and extend the hemostatic effects of gastrointestinal (GI) bleeding during a variety of endoscopy procedures.

PanTheryx™ is the leading nutrition and biotechnology company committed to the global commercialization of bovine colostrum-based health and wellness solutions. From establishing ourselves as the world's premier supplier of colostrum, to driving cutting edge research, to commercializing novel solutions, we are dedicated to harnessing the power of nature's superfood to develop revolutionary approaches to human and animal health.

Paragon 28 was established in 2010 as an orthopedic foot and ankle company. The name "Paragon 28" was chosen to show that we are exclusively a foot and ankle company, with the "28" representing the number of bones in the foot. We will remain true to that vision. Paragon 28 was started as a small, family-based company and we have kept those core ideals as we have grown. Our mission is to strategically build a company around the core principles that drive innovation and quality. Relentlessly working to advance the science behind foot and ankle surgery, Paragon 28 is passionate about and committed to: - Creation and Innovation: Blending different surgical philosophies from various global thought leaders to develop bio-mechanically and clinically relevant surgical solutions. - A Focus on Service: A customer service based, dedicated, and highly trained distribution network to the foot and ankle market. - Efficient Practices: Meeting the needs of increasing pricing pressures and reimbursement while continuing to develop cutting-edge surgical implants. - Practical and Comprehensive Solutions: Creating complete surgeon-centric systems, specialty instruments, and next generation implants to solve real world issues faced by foot and ankle surgeons. - Research Motivated: Improving clinical outcomes through meaningful and unbiased research. We are ready to embrace research data regardless of marketing impact. Motivation, competition and the desire to learn are unique characteristics that are incredibly valuable to our success. Paragon 28's work environment is modern and exciting. We are seeking experienced and energetic individuals to join our team in areas of Quality, Engineering, Marketing, Sales, Administration and Accounting.

PCM Trials is leading the way in mobile research and decentralized clinical trials. Since 2008, PCM Trials has led the way in mobile research. Our Certified Mobile Research Nurses (CMRNs) are driving the shift to patient-centric, decentralized clinical trials, giving individuals the flexibility to engage in research studies in the ways that work best for them and expanding opportunities for participation. PROVEN RESULTS Faster Enrollment | Higher Retention | Improved Adherence | Greater Diversity | Uncompromised Data Quality PCM Trials has worked on 270+ protocols for 130+ sponsors and done 29,000+ visits.

PhotonPharma is an immuno-oncology company with a break-through technology that stimulates a patient's own immune system to seek out and destroy their cancer cells. We have a patent protected process that precisely inactivates DNA/RNA of a patient's own tumor cells while leaving the cells alive with all of unique tumor specific antigen targets (neoantigens) intact. The process is simple, fast and inexpensive. A patient's tumor cells can be extracted, inactivated and administered back on the same day. Efficacy and safety has been demonstrated in a dog trial (companion animals) and in mouse studies.

Drug discovery just got a modern upgrade. Pluto is the collaborative, AI-powered solution empowering scientific teams to do target and biomarker discovery, faster than ever before. Build your biomarker and target lists, track status, priority, and evidence in powerful reports. Visualize and analyze multi-omics data sets with no coding required, and create compelling figures for high-impact presentations. Integrate the wealth of knowledge from published literature and data sets to gain a competitive advantage and derisk projects earlier for better results.

Respirogen's technology will provide oxygen independent from damaged lungs. Acute respiratory distress syndrome (ARDS) is an acute severe lung disease commonly encountered in intensive care units (ICU). It can be caused by several triggers, including pneumonia or trauma. It is characterized by widespread injury of the alveolar–capillary membrane, resulting in protein rich noncardiogenic pulmonary edema (fluid accumulation in the lungs) and acute respiratory failure (ARF). ARDS results in severe hypoxaemia, which is refractory to oxygen treatment and requires assisted ventilation.

Reven Pharmaceuticals is a privately-held clinical-stage biopharmaceutical company founded in 1999.

RheumaGen is the only cell and gene therapy company editing the HLA gene to cure autoimmune diseases at their source.

Sana is a digital heath company driven by 25 years of research into relief for symptoms of chronic pain and insomnia. Sana is developing the first non-invasive, comfortable bio-therapeutic device capable of inducing a deep restorative state of relaxation to alleviate pain and tension. The device provides relief in just 10 minutes through the use of audio-visual neuromodulation, and is currently undergoing FDA certification and clinical trials.

SeaStar Medical is a commercial-stage medical technology company based in Denver, Colorado, focused on developing extracorporeal therapies to combat excessive inflammation in critically ill patients. Incorporated in 2020, the company aims to improve patient outcomes by transforming immune responses or removing harmful cytokines that contribute to organ failure. The flagship product, the Selective Cytopheretic Device (SCD), is designed to neutralize overactive immune cells and halt cytokine storms, which can lead to severe hyperinflammation. SeaStar Medical also offers QUELIMMUNE (SCD-PED), the first FDA-approved treatment for life-threatening acute kidney injury in critically ill pediatric patients. The company has received Breakthrough Device Designation for multiple therapeutic indications, facilitating a faster approval process. Led by a team of experienced professionals, including critical care physicians, SeaStar Medical targets critical care clinicians and hospitals, providing innovative solutions for managing severe inflammatory conditions.

Securisyn Medical is dedicated to creating and cultivating an approach to airway management that will enhance airway safety, prevent unplanned extubation and its associated complications, provide peace of mind for patients, their families, and practitioners and decrease healthcare costs through ethical, profitable, and sustainable business practices.

Delivering life changing & first-in-class therapies to patients suffering from debilitating diseases #Science #GeneTherapy #Biotechnology #Medicine #Innovation

SomaLogic is a biotechnology company that offers the SomaScan® Platform, the only scalable proteomics platform on the market known for its precision.

Sudhin Biopharma Co. is a biotechnology company developing efficient continuous biological manufacturing processes for therapeutic biologicals, sweet proteins, cell therapies and biological roducts.

Tensentric has one focus: the design and manufacturing of medical devices and in vitro diagnostic systems. This narrow focus and expertise is tailored to meet the specific needs of each of our clients and lets us design as efficiently as possible. Tensentric is ISO13485:2003 certified and can manage the development of a medical device from initial concept through design verification and small quantity controlled builds for clinical trials (not for sale). Tensentric's team of engineers average over 20 years of professional experience and have collectively worked on over 350 medical device design and development projects with over 75 patents to their credit.

Headquartered in Lakewood, Colorado, Terumo Blood and Cell Technologies provides blood component, therapeutic apheresis and cellular technologies serving customers in more than 130 countries.

Tolmar is a Northern Colorado based pharmaceutical research, development, manufacturing and commercial operations company. Tolmar develops and manufactures both proprietary and generic pharmaceutical products with specific focus in dermatology, oncology, and specialty injectable therapeutic areas.

TopoGEN is a research diagnostics company that provides innovative products and services for researchers working with topoisomerases and engaged in mechanism based drug discovery and development. The company was created by topo research active scientists who understand the needs and the restraints placed on other cancer researchers or those working in areas peripheral to topoisomerases. Top-selling products include: -Drug Screening Kits to identify topoisomerase active drugs for use in cancer chemotherapy and antibacterial applications -Assay Kits for assaying prokaryotic and eukaryotic topoisomerases (type I, II, IV, gyrase), both in vitro and in vivo -A complete line of DNA substrates and DNA cleavage targets, topoisomerase inhibitors, topoisomerase antibodies, and kit replenishment reagents Our contract screening service offers you powerful, mechanism based custom screens developed and conducted entirely in house. Our cell based (in vivo) screens for detecting topoisomerase I and II poisons in the context of the cancer cell represents the new gold standard for identification of novel anti cancer agents. Since the early 1990s TopoGEN has maintained a dedicated clientele around the world. We offer substantial product support, data interpretation and consultation advice. When you become our customer, we become your partner in research. We review your data and offer valuable input. Please contact us for further information about how we can assist your research goals.

TranS1 is a pioneer in spine technology innovation and is focused on Building Better Pathways™ to the spine. Since its inception, TranS1 has designed, developed, and commercialized transformational approaches to the spine used by thousands of surgeons to minimize the damage associated with traditional surgical approaches. TranS1 believes that the process of Building Better Pathways™ to the spine starts with solving true unmet clinical needs and ends with creating a value-based solution for surgeons, patients, and the healthcare system. trans1.com/ifu MKT-52205.A

Developing investigational treatments to attack liver metastases and pancreatic solid tumors and stimulate the immune system by delivering a combination of immunotherapies directly to the site of disease.

For patients and doctors battling chronic resistant infections, Validus Cellular Therapeutics is developing VCT-101, a novel preclinical stage anti-infective therapy unlike current small molecule antibiotics which are susceptible to resistance and are limited accessing infections. VCT-101 is a cell therapy to be given with standard of care antibiotic regimens to successfully treat of chronic infections through direct bacterial killing and immune system boosting mechanisms.

Simplifying Cancer's Complexities. With the complexities of cancer care exploding due to the paradigm shift towards precision medicine, we saw a need for a platform that actively assists clinicians. We call this Halo Intelligence. Halo Intelligence is the first whole knowledge system that brings together everything clinicians need to find the right treatment plan for every patient, every time. It does this by distilling data from all aspects of the VieCure EcoSystem. The end result is a seamless marriage of artificial intelligence and the clinicians' own natural intelligence creating what we call, The Halo Effect. https://www.viecure.com/careers

Vivaldi Biosciences is developing vaccines for protection against epidemic and pandemic viral respiratory diseases using its Delta NS1 vector and innovative cell-based production technologies. Vivaldi’s DeltaFLU universal influenza vaccine is in Phase 2 clinical development. Its Delta-19 universal influenza/Covid-19 vaccine will enter clinical trials in 2021. Delta NS1 is a versatile and robust technology platform for self-adjuvanting vaccines administered by nasal spray. Delta NS1 is a replication-deficient vaccine vector based on a genetically modified, safely attenuated influenza virus strain. Delta NS1-based vaccines have the unique ability to rapidly induce interferon, generating protection against circulating viruses entering the nasal passages, and activating systemic antibody and cell-based protective immunity.

Vivos is a Massachusetts-based medical technology firm that researches and develops oral therapies for the treatment of dentofacial abnormalities, and sleep apnea disorders.

In 1991, Cheri Casey made the decision to begin her own medical research company. Stemming from her deep-rooted passion to continually seek better medicine. In 25 years of medical research, Western States Clinical Research (WSCR), Inc. has conducted over 150 research studies. This has contributed in a significant way to the advancement of current medications and the implementation of new ones. Some medications WSCR, Inc. participated in researching, that are worthy of mention according to the Director Cheri Casey, include Tudorza, Spiriva, Nicotine Patches and Humira. These drugs were researched in their early stages with the help of WSCR, Inc. and other sites across the country and around the world. Medical research is an integral step in the development of new medications. The purpose of medical research is to study the safety and efficacy of new medications before they are sold to the general- public. WSCR, Inc. conducts medical research studies in a wide variety of therapeutic fields. WSCR, Inc's team of clinical research coordinators have a wide breadth of medical and clinical experience. They are constantly striving to expand their knowledge and partake in continuing education to maintain certifications and stay at the cusp of innovation for the research and development field. Our website contains information for physicians, pharmaceutical companies and individuals interested in participating in clinical research. OUR MISSION is to protect human subjects by committing to the ethical conduct of medical research and adhering to regulatory expectations. Western States Clinical Research, Inc. works diligently to provide high quality research and usable data for use in the development of better medicine for all.

Xtremity is a premium medical device brand that develops advanced prosthetic socket technology.

ZimVie is a global leader in dental implants and spine innovations. Advancing clinical technology foundational to restoring daily life.

Zynex, Inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. Zynex Medical is a provider of electrotherapy products for home use. Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic applications within neurology disciplines. Zynex Medical's product line is fully developed, FDA/CE cleared, commercially sold, and has been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex Monitoring Solutions and Zynex NeuroDiagnostics are currently both in the development stages without any significant revenues.